异动解读|强生盘中上涨3.07%,财报后机构下调目标价幅度有限且企业审查预期升温

行情直击
Oct 15

10月15日,强生盘中上涨3.07%,报260.64美元/股,成交额3.68亿美元。

消息面上,公司此前披露第三季度调整后每股收益2.59美元、高于预期,营收253.99亿美元,同比增长5.9%,并上调全年销售额和调整后每股收益指引。尽管多家机构在业绩后小幅下调目标价,如富国银行降至275美元、雷蒙德詹姆斯降至278美元,但调整幅度有限。

同时,市场关注其12月企业审查,管理层或进一步更新2027年销售、自由现金流、每股收益及骨科业务分拆后的长期目标,提升中长期预期清晰度。

(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10